Healthcare ❯ Pharmaceuticals ❯ Biotechnology ❯ Market Trends
Its 0.09% fee and MSCI ACWI IMI coverage offer a simple one‑fund solution that still concentrates in U.S. mega‑caps and technology, forcing investors to trade simplicity for overlap or higher yield elsewhere.